TPRKB protein acts as a potential inhibitor of the binding of p53-related protein kinase PRPK to p53 [37], whereas T-Complex 1 and Olftactomedin 1 promote proliferation of cancer cells [38,39]. This evidence concerns the gene TP53 and cancer.